Cawachi

Cawachi EBITDA per Share

The EBITDA per Share of Cawachi (2664.T) as of Nov 4, 2026 is 300.92 JPY. In the previous year, EBITDA per Share was 530.79 JPY — a change of -43.31% (lower).

EBITDA per Share

300.92JPY

YoY

-43.31%

Last updated:

EBITDA per Share of Cawachi is 2026 300.92 JPY. EBITDA per Share of Cawachi was 2025 530.79 JPY. It decreases by -43.31% lower compared to the previous year.

The Cawachi EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2019
393.41 JPY
Jan 1, 2020
454.42 JPY
Jan 1, 2021
672.39 JPY
Jan 1, 2022
540.84 JPY
Jan 1, 2023
488.43 JPY
Jan 1, 2024
531.47 JPY
Jan 1, 2025
530.79 JPY
Jan 1, 2026
300.92 JPY
The Cawachi EBITDA per Share history
YEAREBITDA per ShareYoY
300.92JPY-43.31%
530.79JPY-0.13%
531.47JPY+8.81%
488.43JPY-9.69%
540.84JPY-19.56%
672.39JPY+47.97%
454.42JPY+15.51%
393.41JPY-3.99%
409.78JPY-10.42%
457.45JPY+8.53%
421.48JPY+25.02%
337.13JPY-33.65%
508.07JPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cawachi Stock analysis

What does Cawachi do? Cawachi Ltd. generates revenue through the sale of pharmaceutical products such as cold medicines, digestive medicines, vitamin tablets, eye drops, and nursing care items. The company also sells cosmetics including basic skin care, makeup, and men's cosmetics, along with miscellaneous goods like detergents, toilet paper, pet items, and milk powders. Food products such as processed foods, dairy, confectioneries, and beverages are sold through its drugstores. The primary customers are retail consumers seeking health, beauty, and household essentials. The business segments include pharmaceuticals, cosmetics, miscellaneous goods, and food products, all distributed via Cawachi's drugstore network. Cawachi Ltd. operates a chain of drugstores that offer a wide range of health and personal care products. The company's product portfolio spans multiple categories, from medicine to daily necessities, targeting both individual shoppers and families. Its drugstores serve as one-stop shops for customers needing everyday items, combining health-focused products with general household goods. The business model relies on high-volume sales of these diverse product lines to drive profitability. The company's revenue streams are derived from direct sales to end consumers through its physical drugstore locations. Cawachi Ltd. does not mention any additional revenue sources such as online sales, subscriptions, or licensing. The focus remains on selling the listed product categories to retail customers in its drugstore network, with no indication of partnerships or third-party services. The business description emphasizes the range of products sold rather than specific customer demographics or pricing strategies. Cawachi is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cawachi stock

EBITDA per Share of Cawachi is 300.92 JPY in 2026.

EBITDA per Share of Cawachi changed from 530.79 JPY to 300.92 JPY, representing a -43.31% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Cawachi since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Cawachi

All Key Metrics — Cawachi